Nuclear Medicine and Biology
Volume 35, Issue 4 , Pages 425-432 , May 2008

Method for stabilizing non carrier added 2-[18F]fluoromethyl-l-phenylalanine, a new tumour tracer, during radiosynthesis and radiopharmaceutical formulation

Received 16 July 2007 ,Revised 21 December 2007 ,Accepted 11 January 2008.

References 

  1. Jager PL, Vaalburg W, Pruim J, De Vries E, Langen KJ, Piers DA. Radiolabeled amino acids: basic aspects and clinical applications in oncology. J Nucl Med. 2001;42(3):432–445
  2. Laverman P, Boerman OC, Corstens FHM, Oyen WJG. Fluorinated amino acids for tumour imaging with positron emission tomography. Eur J Nucl Med. 2002;29:681–690
  3. Pauleit D, Zimmermann A, Stoffels G, Bauer D, Risse J, Fluss MO, et al. 18F-FET PET compared with 18F-FDG PET and CT in patients with head and neck cancer. J Nucl Med. 2006;47(2):256–261
  4. Rau F, Weber WA, Wester HJ, Herz M, Becker I, Kruger A, et al. O-(2-[(18)F]Fluoroethyl)-l-tyrosine (FET): a tracer for differentiation of tumour from inflammation in murine lymph nodes. Eur J Nucl Med Mol Imaging. 2002;29(8):1039–1046
  5. Miyagawa T, Oku T, Uehara H, Desai R, Beattie B, Tjuvajev J. “Facilitated” amino acid transport is upregulated in brain tumors. J Cereb Blood Flow Metab. 1998;18:500–509
  6. Hamacher K, Coenen HH. Efficient routine production of the 18F-labelled amino acid O-(2-[18F]fluoroethyl)-l-tyrosine. Appl Radiat Isotopes. 2002;57(6):853–856
  7. Kersemans V, Cornelissen B, Kersemans K, Bauwens M, Achten E, Dierckx RA. In vivo characterization of 123/125I-2-iodo-l-phenylalanine in an R1M rhabdomyosarcoma athymic mouse model as a potential tumor tracer for SPECT. J Nucl Med. 2005;46(3):532–539
  8. Kersemans K, Bauwens M, Lahoutte T, Bossuyt A, Mertens J. In vivo PET evaluation in tumour-bearing rats of 2-[18F]fluoromethyl-l-phenylalanine as a new potential tracer for molecular imaging of brain and extra-cranial tumours in humans with PET. Nucl Instrum Methods Phys Res Sect A Accel Spectrom Detect Assoc Equip. 2007;571(1-2):151–154
  9. Swain CG, Spalding RET. Mechanism of acid catalysis of the hydrolysis of benzyl fluoride. JACS. 1960;82:6104–6107
  10. Delpuech JJ, Beguin C. Benzyl fluoride solvolysis in formic acid. Bull Soc Chim Fr. 1967;3:791–795
  11. Thierry J, Yue C, Potier P. 2-Phenylisopropyl and t-butyl trichloroacetimidates: useful reagents for ester preparation of N-protected amino acids under neutral conditions. Tetrahedron Lett. 1998;39(12):1557–1560
  12. Bedel S, Ulrich G, Picard C. Alternative approach to the free radical bromination of oligopyridine benzylic-methyl group. Tetrahedron Lett. 2002;43(9):1697–1700
  13. McDonald IA, Nyce PL, Jung MJ, Sabol JS. Syntheses of dl-2-fluoromethyl-p-tyrosine and dl-2-(difluoromethyl)-p-tyrosine as potential inhibitors of tyrosine hydroxylase. Tetrahedron Lett. 1991;32(7):887–890
  14. Wuest F, Mueller M, Bergmann R. Synthesis of 4-([18F] fluoromethyl)-2-chlorophenylisothiocyanate: a novel bifunctional 18F-labelling agent. Radiochimica Acta. 2004;92(4-6):349–353
  15. Petric A, Barrio JR, Namavari M, Huang S, Satyamurthy N. Synthesis of 3b-(4-[18F]Fluoromethylphenyl)-and 3b-(2-[18F]Fluoromethylphenyl)-2b-carboxylic acid methyl esters: new ligands for mapping brain dopamine transporter with PET. Nucl Med Biol. 1999;26(5):529–535
  16. Magata Y, Lang L, Kiesewetter DO, Jagoda EM, Channing MA, Eckelman WC. Biologically stable [18F]-labeled benzylfluoride derivatives. Nucl Med Biol. 2000;27(2):163–168

☆ The first author is currently in training as a PhD student.

PII: S0969-8051(08)00036-X

doi: 10.1016/j.nucmedbio.2008.01.003

Nuclear Medicine and Biology
Volume 35, Issue 4 , Pages 425-432 , May 2008

Article Tools

* Image Usage & Resolution